https://sputnikglobe.com/20211129/rdif-new-sputnik-v-version-adapted-to-omicron-variant-in-development-1091113995.html

RDIF: New Sputnik V Version Adapted to Omicron Variant in Development

Sputnik International

MOSCOW (Sputnik) - A new version of the Sputnik V COVID-19 vaccine adapted to the Omicron coronavirus variant is in development, the Russian Direct Investment... 29.11.2021, Sputnik International

2021-11-29T15:18+0000

omicron covid strain

sputnik v vaccine

https://cdn1.img.sputnikglobe.com/img/07e5/0a/14/1090082349_0:171:3073:1899_1920x0_80_0_0_976adcbafbced02da931db6446305f74.jpg

The RDIF mentioned that Sputnik V and Sputnik Light vaccines "have proven to be highly effective against all variants of SARC-Cov-2 known to date."The vaccine maker is confident that Sputnik V and Sputnik Light will be able to neutralize Omicron "as they have highest efficacy against other mutations," the RDIF added.The World Health Organization (WHO) has labeled the Omicron variant, first identified in South Africa, as one of concern. The new strain is reported to carry 32 mutations, which possibly makes it more transmissible and dangerous. Cases of the new variant have already been confirmed in multiple countries, including Israel, Germany, Italy and the Czech Republic.

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

2021

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

News

en_EN

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

1920

1080

true

1920

1440

true

https://cdn1.img.sputnikglobe.com/img/07e5/0a/14/1090082349_159:0:2890:2048_1920x0_80_0_0_8cec2ab02e7fe6a61dca1406a2e49769.jpg

1920

true

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

Sputnik International

sputnik v vaccine

RDIF: New Sputnik V Version Adapted to Omicron Variant in Development

15:18 GMT 29.11.2021

© AP Photo / Pavel GolovkinIn this Thursday, Dec. 10, 2020 file photo, a vial with Russia's Sputnik V coronavirus vaccine in a medical room rests on a table prior to a vaccination in Moscow. The South African drug regulator has rejected the Russian-made coronavirus vaccine Sputnik V, citing some safety concerns the manufacturer wasn't able to answer. In a statement on Tuesday, the country's regulator, also known as SAHPRA, said the request for Sputnik V to be authorized could “not be approved at this time,” referring to past failed HIV vaccines that used a similar technology.

In this Thursday, Dec. 10, 2020 file photo, a vial with Russia's Sputnik V coronavirus vaccine in a medical room rests on a table prior to a vaccination in Moscow. The South African drug regulator has rejected the Russian-made coronavirus vaccine Sputnik V, citing some safety concerns the manufacturer wasn't able to answer. In a statement on Tuesday, the country's regulator, also known as SAHPRA, said the request for Sputnik V to be authorized could “not be approved at this time,” referring to past failed HIV vaccines that used a similar technology. - Sputnik International, 1920, 29.11.2021

MOSCOW (Sputnik) - A new version of the Sputnik V COVID-19 vaccine adapted to the Omicron coronavirus variant is in development, the Russian Direct Investment Fund (RDIF) said on Monday.

The RDIF mentioned that Sputnik V and Sputnik Light vaccines "have proven to be highly effective against all variants of SARC-Cov-2 known to date."

"Nonetheless the Gamaleya Institute, based on existing protocols of immediately developing vaccine versions for variants of concern, has already begun developing the new version of Sputnik vaccine adapted to Omicron," the RDIF said in a statement.

The vaccine maker is confident that Sputnik V and Sputnik Light will be able to neutralize Omicron "as they have highest efficacy against other mutations," the RDIF added.

"In an unlikely case such modification is needed, the new Sputnik Omicron version can be ready for mass-scale production in 45 days. Several hundred million Sputnik Omicron boosters can be provided to international markets already by Feb 20, 2022 with over 3 billion doses available in 2022," RDIF CEO Kirill Dmitriev said.

The World Health Organization (WHO) has labeled the Omicron variant, first identified in South Africa, as one of concern. The new strain is reported to carry 32 mutations, which possibly makes it more transmissible and dangerous.

Cases of the new variant have already been confirmed in multiple countries, including Israel, Germany, Italy and the Czech Republic.